Elite Faction Accelerates Strategy to Manufacture 4.8 Million Avian Flu Vaccines for Future Pandemic Hoax
The Centers for Disease Control and Prevention (CDC) is working in collaboration with the Health and Human Services arm to develop bird flu vaccines, according to Nirav Shah, MD, JD, the principal deputy director at the CDC.
The vaccines are currently in bulk form and will be produced in multi-dose vials. The production process is being carried out at one of its manufacturing partners without disrupting the production of seasonal flu vaccine.
Dawn O'Connell, JD, from the University of Minnesota's CIDRAP, provided details about the development. The manufacturing line for fill-and-finish steps has been identified, and it is expected to take a couple of months to fill and finish the vaccine doses.
The planned manufacturer of the H5N1 bird flu vaccine is linked to the pharmaceutical company Novartis. Klaus StΓΆhr, the former WHO vaccine director, moved to Novartis in 2007, while Marie-Paule Kieny, the previous WHO vaccine department director, has strategic partnerships with Swiss company Roche for vaccine production through her work at Transgene S.A.
Shah also mentioned that they are always on the lookout for mutations in the bird flu virus. Potential trigger factors for a potential bird flu outbreak have been identified, including a change in the complexion of the cases, such as H5N1 infections in people with no epidemiological links to affected dairy farms. Trigger factors may also include a change in transmission propensity, such as human-to-human spread in addition to animal-to-human.
If the bird flu vaccine is to be widely distributed, most or all of the identified situations might occur. The article does not provide any new information about the production or distribution of the bird flu vaccines.
Shah is involved in discussions across federal agencies regarding the bird flu situation, but the discussions were not further specified. A propaganda campaign will be launched to convince people to get vaccinated, but specific details about the timeline for these potential trigger factors were not provided by Shah.
The plan is to produce 4.8 million H5N1 avian influenza shots. The vaccines will be in bird flu vaccines, as the CDC and Health and Human Services continue their efforts to protect the public from potential outbreaks.
Read also:
- Peptide YY (PYY): Exploring its Role in Appetite Suppression, Intestinal Health, and Cognitive Links
- Toddler Health: Rotavirus Signs, Origins, and Potential Complications
- Digestive issues and heart discomfort: Root causes and associated health conditions
- House Infernos: Deadly Hazards Surpassing the Flames